The latest closing stock price for Aerovate Therapeutics as of January 17, 2025 is 2.58.
An investor who bought $1,000 worth of Aerovate Therapeutics stock at the IPO in 2021 would have $-887 today, roughly -1 times their original investment - a -42.02% compound annual growth rate over 4 years.
The all-time high Aerovate Therapeutics stock closing price was 30.75 on April 01, 2024.
The Aerovate Therapeutics 52-week high stock price is 32.41, which is 1156.2% above the current share price.
The Aerovate Therapeutics 52-week low stock price is 1.25, which is 51.6% below the current share price.
The average Aerovate Therapeutics stock price for the last 52 weeks is 10.26.
An investor who bought $1,000 worth of Aerovate Therapeutics stock at the IPO in 2021 would have $-887 today, roughly -1 times their original investment - a -42.02% compound annual growth rate over 4 years.
The all-time high Aerovate Therapeutics stock closing price was 30.75 on April 01, 2024.
The Aerovate Therapeutics 52-week high stock price is 32.41, which is 1156.2% above the current share price.
The Aerovate Therapeutics 52-week low stock price is 1.25, which is 51.6% below the current share price.
The average Aerovate Therapeutics stock price for the last 52 weeks is 10.26.